Skip to content
10-Q

Quarterly Report

CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. CBIH

0001683168-26-001190

← back to feed
Filed
Feb 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Feb 18, 2026 11.63B sh
Shares Diluted Q2 2026 · Nov 30, 2025 11.63B sh
Shares Diluted Q2 2026 · Nov 30, 2025 11.63B sh
Shares Diluted Q2 2026 · Nov 30, 2024 10.5B sh
Shares Diluted Q2 2026 · Nov 30, 2024 10.5B sh
Operating Cash Flow Q2 2026 · Nov 30, 2025 −$109.21K
Operating Cash Flow Q2 2026 · Nov 30, 2024 −$102.5K
Long Term Debt Q2 2026 · Nov 30, 2025 $249.5K
Long Term Debt Q2 2026 · May 31, 2025 $249.5K
Short Term Debt Q2 2026 · Nov 30, 2025 $14.95K
Short Term Debt Q2 2026 · May 31, 2025 $14.59K
Stockholders Equity Q2 2026 · Nov 30, 2025 −$1.36M
Stockholders Equity Q2 2026 · Aug 31, 2025 −$1.25M
Stockholders Equity Q2 2026 · May 31, 2025 −$1.16M
Stockholders Equity Q2 2026 · Nov 30, 2024 −$1.13M
Stockholders Equity Q2 2026 · Aug 31, 2024 −$1.06M
Stockholders Equity Q2 2026 · May 31, 2024 −$1.08M
Current Liabilities Q2 2026 · Nov 30, 2025 $1.14M
Current Liabilities Q2 2026 · May 31, 2025 $945.96K
Total Liabilities Q2 2026 · Nov 30, 2025 $1.39M
Total Liabilities Q2 2026 · May 31, 2025 $1.2M
Current Assets Q2 2026 · Nov 30, 2025 $22.13K
Current Assets Q2 2026 · May 31, 2025 $29.09K
Total Assets Q2 2026 · Nov 30, 2025 $22.13K
Total Assets Q2 2026 · May 31, 2025 $31.88K
Eps Diluted Q2 2026 · Nov 30, 2025 $0.00
Eps Diluted Q2 2026 · Nov 30, 2025 $0.00
Eps Diluted Q2 2026 · Nov 30, 2024 $0.00
Eps Diluted Q2 2026 · Nov 30, 2024 $0.00
Eps Basic Q2 2026 · Nov 30, 2025 $0.00
Eps Basic Q2 2026 · Nov 30, 2025 $0.00
Eps Basic Q2 2026 · Nov 30, 2024 $0.00
Eps Basic Q2 2026 · Nov 30, 2024 $0.00
Sga Expense Q2 2026 · Nov 30, 2025 $30.97K
Sga Expense Q2 2026 · Nov 30, 2025 $54.28K
Sga Expense Q2 2026 · Nov 30, 2024 $40.13K
Sga Expense Q2 2026 · Nov 30, 2024 $101.42K
Net Income Q2 2026 · Nov 30, 2025 −$116.97K
Net Income Q2 2026 · Nov 30, 2025 −$199.61K
Net Income Q2 2026 · Aug 31, 2025 −$82.65K
Net Income Q2 2026 · Nov 30, 2024 −$79.53K
Net Income Q2 2026 · Nov 30, 2024 −$155.83K
Net Income Q2 2026 · Aug 31, 2024 −$76.31K
Operating Income Q2 2026 · Nov 30, 2025 −$95.88K
Operating Income Q2 2026 · Nov 30, 2025 −$170.66K
Operating Income Q2 2026 · Nov 30, 2024 −$59.63K
Operating Income Q2 2026 · Nov 30, 2024 −$157.23K
Gross Profit Q2 2026 · Nov 30, 2025 $42.77K
Gross Profit Q2 2026 · Nov 30, 2025 $58.82K
Gross Profit Q2 2026 · Nov 30, 2024 $66.45K
Gross Profit Q2 2026 · Nov 30, 2024 $236.97K
Cost Of Revenue Q2 2026 · Nov 30, 2025 $10.5K
Cost Of Revenue Q2 2026 · Nov 30, 2025 $18.64K
Cost Of Revenue Q2 2026 · Nov 30, 2024 $7.8K
Cost Of Revenue Q2 2026 · Nov 30, 2024 $16.17K
Revenue Q2 2026 · Nov 30, 2025 $53.27K
Revenue Q2 2026 · Nov 30, 2025 $77.47K
Revenue Q2 2026 · Nov 30, 2024 $74.25K
Revenue Q2 2026 · Nov 30, 2024 $253.14K